Judy C. Boughey
朱迪·博伊
MBBCh
Chair, Division of Breast and Melanoma Surgical Oncology; Professor of Surgery乳腺与黑色素瘤外科肿瘤学部主任；外科学教授
👥Biography 个人简介
Judy Boughey is Chair of Breast and Melanoma Surgical Oncology at Mayo Clinic and a global leader in axillary lymph node management after neoadjuvant therapy. Her contributions to the SENTINA and SN FNAC trials, and landmark Mayo prospective studies, have fundamentally altered surgical practice for node-positive breast cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
SENTINA Trial
Co-investigator on the SENTINA trial, a landmark European prospective study evaluating sentinel node biopsy timing and accuracy in patients receiving neoadjuvant chemotherapy.
Mayo Clinic Neoadjuvant SLN Studies
Led prospective Mayo Clinic studies validating sentinel lymph node biopsy after neoadjuvant chemotherapy, forming the basis for updated NCCN and ASCO guidelines.
Axillary Surgery De-escalation Protocols
Developed evidence-based protocols for omitting ALND in ypN0 patients after neoadjuvant therapy, significantly reducing surgical morbidity at Mayo and nationally.
Representative Works 代表性著作
Surgical axillary management of node-positive breast cancer patients treated with neoadjuvant chemotherapy: the Mayo Clinic prospective study
Annals of Surgery (2014)
Validated SLN biopsy accuracy post-neoadjuvant chemotherapy, supporting de-escalation of axillary surgery in responders.
Factors associated with false-negative sentinel node biopsy in breast cancer patients with positive sentinel nodes on preoperative ultrasound
Journal of the American College of Surgeons (2018)
Identified predictors of false-negative SLN results, informing patient selection for axillary de-escalation.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 朱迪·博伊 的研究动态
Follow Judy C. Boughey's research updates
留下邮箱，当我们发布与 Judy C. Boughey（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment